Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Longevity  

The central 
growth driver 
in the healthcare sector

Longevity is no longer just a medical trend – it is one of the key growth drivers in global healthcare. The focus is shifting from simply extending life to improving quality of life: detecting diseases earlier, sustainably influencing their progression, and maintaining functional independence for as long as possible. Discover which growth areas are emerging and how you can participate through Bellevue funds.

Investing in a long and healthy life

While life expectancy continues to rise, one question is increasingly coming into focus in healthcare:

How can additional years of life be lived in good health, actively, and independently?

Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2019 (GBD 2019) Results.

 

This is exactly where a new generation of innovation is emerging. New approaches in prevention, diagnostics, and therapies make it possible to detect diseases earlier, influence their progression in a targeted way, and maintain physical and cognitive function, and thus quality of life, over the long term.

Supported by data-driven technologies and artificial intelligence, the healthcare system is evolving rapidly.

Longevity therefore represents a clear investment theme that is structurally embedded in Bellevue Asset Management’s investment products.

 

Portfolio data is based on fund holdings as of February 27, 2026. Currency hedging and cash are excluded from all calculations. This analysis is for informational purposes only and does not constitute investment advice.

 

Learn more about our funds

Growth drivers

Bellevue Asset Management – Ahead through foresight

Bellevue has been intensively engaged with the topic of longevity for many years. In our view, longevity represents medical innovation at the highest level – and is therefore structurally embedded in Bellevue Asset Management’s healthcare funds and mandates. Bellevue addresses this theme through active, bottom-up stock picking focused on companies that translate medical progress into sustainable economic value.

Through continuous analysis and classification of innovations in prevention, diagnostics, drug development, and medical technology, Bellevue has built deep expertise. This long-standing experience makes it possible to identify developments early and invest specifically in companies driving solutions for a longer and healthier life.

Would you like to explore the topic further?

We would be happy to send you the white paper. Please fill out the form below.

For professional investors only.

*indicates required fields.
We respect your privacy and do not sell, rent or loan any identifiable information collected on this site. Any information that you give us will be treated with the utmost care and security. It will not be used in ways to which you have not consented.